NeuroBo Pharmaceuticals, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
NRBO on Nasdaq
Location
545 Concord Avenue, Suite 210, Cambridge, MA

Insiders trading volume in the past year

NeuroBo Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Dong A St Co., Ltd 10%+ Owner $20.1M +$18M +859% Sep 18, 2024
E&Investment, Inc. 10%+ Owner $18.8M Jul 26, 2022
Goldman Sachs Group Inc 10%+ Owner $3.82M Nov 16, 2022
Na Yeon Kim Director, 10%+ Owner $945K Jul 27, 2023
Hyung Heon Kim CEO & President, Director $240K Aug 11, 2024
Marshall H. Woodworth Chief Financial Officer $105K Mar 1, 2024
D. Gordon Strickland Director $54.9K Jun 7, 2024
Jason L. Groves Director $54.9K Jun 7, 2024
Michael Salsbury Director $54.9K Jun 7, 2024
Andrew I. Koven Director $54.9K Jun 7, 2024
Mark A. Glickman Director $30.5K Jun 7, 2024
James Patrick Tursi Director $28.4K Jun 7, 2024
Richard Kang Director Jun 9, 2022
Ben Gil Price CEO and President Nov 3, 2021
Joseph Hooker Interim CEO and President Jan 12, 2023

Recent Insider Transactions by Companies or Individuals for NeuroBo Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.